Neuroendocrine tumors (NETs) represent a complex group of cancers that can develop anywhere in the body where neuroendocrine cells are present. While these tumors remain relatively rare, understanding their risk factors becomes crucial for early detection and effective neuroendocrine tumor treatment. Medical professionals and patients alike benefit from comprehensive knowledge about what increases the likelihood of developing these unique cancers.
